INFU InfuSystem Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: INFU

Price (delayed)

$12.075

Market cap

$240.5M

P/E Ratio

28.75

Dividend/share

N/A

EPS

$0.42

Enterprise value

$262.79M

?
Relative Growth: Rel. Growth: 59
Relative Strength: Rel. Strength: 80
Relative Valuation: Rel. Valuation: 76
Relative Profitability: Rel. Profitability: 79

InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided ...

Highlights
The stock's price to earnings (P/E) is 87% less than its 5-year quarterly average of 223.3
The company's EPS has surged by 83% YoY and by 11% QoQ
The debt has contracted by 24% YoY but it has grown by 2.1% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.infusystem.com
Peers: CRVL

Key stats

What are the main financial stats of INFU

INFU stock price

How has the InfuSystem Holdings stock price performed over time
Intraday
-0.86%
1 week
0.29%
1 month
-1.99%
1 year
13.59%
YTD
34.62%
QTD
25.13%

Financial performance

How have InfuSystem Holdings's revenue and profit performed over time
Revenue
$143.34M
Gross profit
$82.35M
Operating income
$13.25M
Net income
$8.54M
Gross margin
57.5%
Net margin
6%
The company's net income has surged by 68% YoY and by 8% QoQ
The net margin has soared by 67% YoY and by 7% from the previous quarter
The operating income has grown by 28% YoY and by 2.9% from the previous quarter
The company's operating margin rose by 24% YoY and by 2.2% QoQ

Price vs fundamentals

How does INFU's price correlate with its fundamentals

Growth

What is InfuSystem Holdings's growth rate over time

Valuation

What is InfuSystem Holdings stock price valuation
INFU P/E details
P/E
28.75
P/B
4.12
P/S
1.69
EV/EBIT
19.74
EV/EBITDA
9.96
EV/Sales
1.83
The stock's price to earnings (P/E) is 87% less than its 5-year quarterly average of 223.3
The company's EPS has surged by 83% YoY and by 11% QoQ
The stock's P/B is 22% above its last 4 quarters average of 3.4 and 12% above its 5-year quarterly average of 3.7
The equity rose by 8% YoY
INFU's P/S is 22% above its last 4 quarters average of 1.4 and 7% above its 5-year quarterly average of 1.6
InfuSystem Holdings's revenue has increased by 2.5% YoY

Efficiency

How efficient is InfuSystem Holdings business performance
The ROA has soared by 76% YoY and by 9% from the previous quarter
The ROE has soared by 63% YoY and by 6% from the previous quarter
INFU's return on invested capital has surged by 50% year-on-year and by 5% since the previous quarter
The company's return on sales rose by 26% YoY and by 2.2% QoQ

Dividends

What is INFU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INFU.

Financial health

How did InfuSystem Holdings financials performed over time
The total assets is 153% greater than the total liabilities
The quick ratio is up by 21% QoQ and by 16% YoY
The current ratio has grown by 17% from the previous quarter and by 14% YoY
The debt is 61% less than the equity
InfuSystem Holdings's debt to equity has decreased by 30% YoY
The debt has contracted by 24% YoY but it has grown by 2.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.